IP Library Assignment 022529/0584
Patent Assignment
Reel/Frame 022529/0584

Assignment of Assignor's Interest

Recorded: 2009-04-13 Pages: 5
Assignors
DRUZGALA, PASCAL
Executed: 2005-06-14
BECKER, CYRUS
Executed: 2005-06-14
Assignee
ARYX THERAPEUTICS, INC.
6300 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Property (1)
Materials and Methods for Treating Coagulation Disorders
Patent: 7,285,671 →
Application: 11/467,813 →
Publication: US 2006/0287388
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Oct 18, 2010
From: ARYX THERAPEUTICS, INC.
To: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
Reel/Frame 025150/0379 →
Assignment of Assignor's Interest Feb 21, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 027738/0001 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 022529 Frame 0584. Assignor(S) Hereby Confirms the Name of the Assignee to Be Aryx Therapeutics and Not Aryx Therapeutics, Inc.. Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0196 →
Assignment of Assignor's Interest Jun 8, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 028347/0389 →
Release of Security Interest Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →
Assignment of Assignor's Interest May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →
Release of Security Interest Oct 4, 2022
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: ESPERO BIOPHARMA, INC.
Reel/Frame 061299/0927 →